Aaron Z Handa, DPM | |
3801 Miranda Ave, Palo Alto, CA 94304-1290 | |
(650) 493-5000 | |
Not Available |
Full Name | Aaron Z Handa |
---|---|
Gender | Male |
Speciality | Podiatrist |
Location | 3801 Miranda Ave, Palo Alto, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144071093 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | EL7046 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Aaron Z Handa, DPM 3801 Miranda Ave, Palo Alto, CA 94304-1290 Ph: () - | Aaron Z Handa, DPM 3801 Miranda Ave, Palo Alto, CA 94304-1290 Ph: (650) 493-5000 |
News Archive
SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for point-of-care medicine, today announced the expansion of the SonoAccess™ iPhone® application to include musculoskeletal specialties. SonoAccess is the first iPhone application to provide physicians with a comprehensive multimedia database of ultrasound resource materials.
Scientists at the Catalan Institute for Water Research have carried out a comprehensive analysis of several viromes from different habitats to explore whether bacteriophages (viruses that infect bacteria) harbor antibiotic resistance genes.
Two new drugs have gained approval from the US Food and Drug Administration (FDA) – one is an antibiotic from Forest Labs and the other a first-time treatment for a neurological disorder developed by Avanir Pharmaceuticals. Another waiting for approval is Biodel's fast-acting insulin Linjeta. On the other hand seven new drugs got rejected including a diabetes drug from Amylin Pharmaceuticals and weight-loss drugs from Arena Pharmaceuticals and Vivus, respectively.
When estrogen-lowering drugs no longer control metastatic breast cancer, the opposite strategy might work. Raising estrogen levels benefited 30 percent of women whose metastatic breast cancer no longer responded to standard anti-estrogen treatment, according to research conducted at Washington University School of Medicine in St. Louis and collaborating institutions.
Researchers at CÚRAM, the SFI Research Centre for Medical Devices based at National University of Ireland Galway, and BIOFORGE Lab, at the University of Valladolid in Spain, have developed an injectable hydrogel that could help repair and prevent further damage to the heart muscle after a heart attack.
› Verified 6 days ago
Elizabeth Anne Reilly, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Palo Alto, CA 94305 Phone: 650-723-4000 | |
Jonathan Jeah Seun, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Dr. Sandra Jay Loving, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Dr. Eghosa Isa, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2943 | |
Dr. Nancy Vilaysak Kim, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Francis Dinh, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 |